Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis
Authors:
- 6 September 2020
- journal article
- research article
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 15 (4) , 874-881
Abstract
Background: Neurocognitive impairments are core early features of psychosis and are observed in those at ultra‐high risk (UHR) for psychosis. The aim of the present study was to explore whether neurocognition is associated with polyunsaturated fatty acids (PUFAs), as has been observed in other clinical populations.Method: Erythrocyte levels of total omega‐3‐and omega‐6 PUFAs the omega‐3/omega‐6 ratio, were measured in 265 UHR individuals. Six domains of neurocognition as well a Composite Score, were assessed using the Brief Assessment of Cognition in Schizophrenia. Pearson's correlations were used to assess the relationship between PUFAs and neurocognition. All analyses were controlled for tobacco smoking.Results: Verbal Fluency correlated positively with eicosapentaenoic acid (P = .024) and alpha‐linolenic acid (P = .01), and negatively with docosahexanoic acid (P = .007) and Working Memory positively correlated with omega‐3/omega‐6 ratio (P = .007).Conclusions: The current results provide support for a relationship between Verbal Fluency and omega‐3 PUFAs in UHR. Further investigation is required to elucidate whether these biomarkers are useful as risk markers or in understanding the biological underpinning of neurocognitive impairment in this population.Keywords
Funding Information
- Stanley Medical Research Institute (07TGF‐1102)
This publication has 46 references indexed in Scilit:
- Comparison of Peripheral and Central Schizophrenia Biomarker ProfilesPLOS ONE, 2012
- Semantic fluency deficits and reduced grey matter before transition to psychosis: A voxelwise correlational analysisPsychiatry Research: Neuroimaging, 2011
- Verbal fluency as a possible predictor for psychosisEuropean Psychiatry, 2010
- General and Specific Cognitive Deficits in Schizophrenia: Goliath Defeats David?Biological Psychiatry, 2008
- Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)Schizophrenia Research, 2008
- Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseasesBiomedicine & Pharmacotherapy, 2006
- The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophrenia Research, 2004
- The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibilityAddiction, 2002
- What's wrong with Bonferroni adjustmentsBMJ, 1998
- The Brief Psychiatric Rating ScalePsychological Reports, 1962